157 related articles for article (PubMed ID: 38023540)
1. Utilizing Ceftazidime/Avibactam Therapeutic Drug Monitoring in the Treatment of Neurosurgical Meningitis Caused by Difficult-to-Treat Resistant
Yasmin M; Nutman A; Wang L; Marshall S; Chen K; Wang J; Yahav D; Lupinsky L; Hujer AM; Bhimraj A; van Duin D; Li J; Bonomo RA
Open Forum Infect Dis; 2023 Nov; 10(11):ofad507. PubMed ID: 38023540
[TBL] [Abstract][Full Text] [Related]
2. Implementation of Chromatic Super CAZ/AVI
Bianco G; Boattini M; Comini S; Leone A; Bondi A; Zaccaria T; Cavallo R; Costa C
Eur J Clin Microbiol Infect Dis; 2022 Sep; 41(9):1165-1171. PubMed ID: 35933457
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of ceftazidime-avibactam in various combinations for the treatment of experimental osteomyelitis due to Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae.
Davido B; Crémieux AC; Vaugier I; Gatin L; Noussair L; Massias L; Laurent F; Saleh-Mghir A
Int J Antimicrob Agents; 2023 Jan; 61(1):106702. PubMed ID: 36476965
[TBL] [Abstract][Full Text] [Related]
4. In vitro activity of ceftazidime-avibactam against Gram-negative strains in Chile 2015-2021.
Torres-Castillo LC; Fandiño C; Ramos MP; Ramos-Castaneda JA; Rioseco ML; Juliet C
J Glob Antimicrob Resist; 2023 Dec; 35():143-148. PubMed ID: 37714380
[TBL] [Abstract][Full Text] [Related]
5. Emergence of ceftazidime/avibactam resistance in carbapenem-resistant Klebsiella pneumoniae in China.
Zhang P; Shi Q; Hu H; Hong B; Wu X; Du X; Akova M; Yu Y
Clin Microbiol Infect; 2020 Jan; 26(1):124.e1-124.e4. PubMed ID: 31494252
[TBL] [Abstract][Full Text] [Related]
6. Emergence of Ceftazidime- and Avibactam-Resistant Klebsiella pneumoniae Carbapenemase-Producing Pseudomonas aeruginosa in China.
Zhu Y; Chen J; Shen H; Chen Z; Yang QW; Zhu J; Li X; Yang Q; Zhao F; Ji J; Cai H; Li Y; Zhang L; Leptihn S; Hua X; Yu Y
mSystems; 2021 Dec; 6(6):e0078721. PubMed ID: 34726488
[TBL] [Abstract][Full Text] [Related]
7. In vitro interaction of ceftazidime-avibactam in combination with different antimicrobials against KPC-producing Klebsiella pneumoniae clinical isolates.
Gaibani P; Lewis RE; Volpe SL; Giannella M; Campoli C; Landini MP; Viale P; Re MC; Ambretti S
Int J Infect Dis; 2017 Dec; 65():1-3. PubMed ID: 28951106
[TBL] [Abstract][Full Text] [Related]
8. In Vitro Evaluation of Increasing Avibactam Concentrations on Ceftazidime Activity against Ceftazidime/Avibactam-Susceptible and Resistant KPC-Producing
Palombo M; Secci B; Bovo F; Gatti M; Ambretti S; Gaibani P
Antibiotics (Basel); 2023 Dec; 12(12):. PubMed ID: 38136741
[TBL] [Abstract][Full Text] [Related]
9. Using Therapeutic Drug Monitoring to Treat KPC-Producing
Yasmin M; Hanrahan J; Marshall S; Lodise TP; Chen L; Perez F; Kreiswirth B; Bonomo RA
Open Forum Infect Dis; 2020 Sep; 7(9):ofaa349. PubMed ID: 32964066
[TBL] [Abstract][Full Text] [Related]
10. Ceftazidime-Avibactam Treatment for Severe Post-Neurosurgical Meningitis and Abscess Caused by Extended-Spectrum β-Lactamase
Ren J; Wang Q; Liu L; Xiao Y; Ji P; Du H; Wang S; Zheng Y; Yang Q
Infect Drug Resist; 2023; 16():1905-1911. PubMed ID: 37020793
[TBL] [Abstract][Full Text] [Related]
11. Colonization by ceftazidime/avibactam-resistant KPC-producing Klebsiella pneumoniae following therapy in critically ill patients.
Gaibani P; Bovo F; Bussini L; Bartoletti M; Lazzarotto T; Viale P; Pea F; Ambretti S
Clin Microbiol Infect; 2023 May; 29(5):654.e1-654.e4. PubMed ID: 36716999
[TBL] [Abstract][Full Text] [Related]
12. Ceftazidime-avibactam in the treatment of infections caused by KPC-producing Klebsiella pneumoniae: factors associated with clinical efficacy in a single-center cohort.
Castón JJ; Gallo M; García M; Cano A; Escribano A; Machuca I; Gracia-Aufinger I; Guzman-Puche J; Pérez-Nadales E; Recio M; Muñoz M; Martínez-Martínez L; Torre-Cisneros J;
Int J Antimicrob Agents; 2020 Sep; 56(3):106075. PubMed ID: 32629116
[TBL] [Abstract][Full Text] [Related]
13. Whole-Genome Sequencing and Molecular Analysis of Ceftazidime-Avibactam-Resistant KPC-Producing
Errico G; Del Grosso M; Pagnotta M; Marra M; Carollo M; Cerquetti M; Fogato E; Cesana E; Gentiloni Silverj F; Zabzuni D; Rossini A; Pantosti A; Tinelli M; Monaco M; Giufrè M
Antibiotics (Basel); 2023 Aug; 12(8):. PubMed ID: 37627702
[TBL] [Abstract][Full Text] [Related]
14. Clinical efficacy of ceftazidime/avibactam combination therapy for severe hospital-acquired pulmonary infections caused by carbapenem-resistant and difficult-to-treat Pseudomonas aeruginosa.
Xu C; Zeng F; Huang Y; Xu Q; Yang Y; Gong W; Shi C; Zhang Y
Int J Antimicrob Agents; 2024 Jan; 63(1):107021. PubMed ID: 37890733
[TBL] [Abstract][Full Text] [Related]
15. Impact of Ceftazidime-Avibactam Treatment in the Emergence of Novel KPC Variants in the ST307-Klebsiella pneumoniae High-Risk Clone and Consequences for Their Routine Detection.
Hernández-García M; Castillo-Polo JA; Cordero DG; Pérez-Viso B; García-Castillo M; Saez de la Fuente J; Morosini MI; Cantón R; Ruiz-Garbajosa P
J Clin Microbiol; 2022 Mar; 60(3):e0224521. PubMed ID: 35107303
[TBL] [Abstract][Full Text] [Related]
16. Resistance to ceftazidime/avibactam in infections and colonisations by KPC-producing Enterobacterales: a systematic review of observational clinical studies.
Di Bella S; Giacobbe DR; Maraolo AE; Viaggi V; Luzzati R; Bassetti M; Luzzaro F; Principe L
J Glob Antimicrob Resist; 2021 Jun; 25():268-281. PubMed ID: 33895414
[TBL] [Abstract][Full Text] [Related]
17. Acquisition of resistance to ceftazidime-avibactam during infection treatment in
García P; Brito B; Alcalde-Rico M; Munita JM; Martínez JRW; Olivares-Pacheco J; Quiroz V; Wozniak A
Front Cell Infect Microbiol; 2022; 12():981792. PubMed ID: 36118031
[TBL] [Abstract][Full Text] [Related]
18. Genetic Diversity and in vitro Activity of Aztreonam/Avibactam and Ceftazidime/Avibactam Against Carbapenem-Resistant
Sun S; Chen K; Kong X; Tian W; Niu S
Infect Drug Resist; 2022; 15():2243-2251. PubMed ID: 35510161
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of Ceftazidime-Avibactam Salvage Therapy in Patients With Infections Caused by Klebsiella pneumoniae Carbapenemase-producing K. pneumoniae.
Tumbarello M; Trecarichi EM; Corona A; De Rosa FG; Bassetti M; Mussini C; Menichetti F; Viscoli C; Campoli C; Venditti M; De Gasperi A; Mularoni A; Tascini C; Parruti G; Pallotto C; Sica S; Concia E; Cultrera R; De Pascale G; Capone A; Antinori S; Corcione S; Righi E; Losito AR; Digaetano M; Amadori F; Giacobbe DR; Ceccarelli G; Mazza E; Raffaelli F; Spanu T; Cauda R; Viale P
Clin Infect Dis; 2019 Jan; 68(3):355-364. PubMed ID: 29893802
[TBL] [Abstract][Full Text] [Related]
20. Acquisition of a Stable and Transferable
Huang J; Zhang S; Zhao Z; Chen M; Cao Y; Li B
Front Cell Infect Microbiol; 2021; 11():658070. PubMed ID: 34354959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
